Pulmonary Emboli without Leg Symptoms, May-Thurner syndrome. Case Report and Review

10.5580/2a7d ◽  
2012 ◽  
Vol 9 (2) ◽  
Keyword(s):  
Case Report ◽  
Pulmonary Emboli

scholarly journals Multiple pulmonary emboli as a result of renal cell carcinoma: A case report

2016 ◽  
Vol 13 (1) ◽  
pp. 267-270 ◽  
Author(s):  
Bing Li ◽  
Hong Zeng ◽  
Mei Ding ◽  
Ping Yang ◽  
Yuquan He
Keyword(s):  
Renal Cell Carcinoma ◽  
Case Report ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Pulmonary Emboli

Management of Pulmonary Emboli During a Spinal Cord Stimulator Trial: A Case Report

2020 ◽  
pp. 51-55
Author(s):  
Varun Rimmalapudi
Keyword(s):  
Spinal Cord ◽  
Case Report ◽  
Spinal Cord Stimulation ◽  
Pulmonary Embolus ◽  
Vena Cava ◽  
Multidisciplinary Care ◽  
Prior History ◽  
Lead Removal ◽  
Pulmonary Emboli ◽  
Spinal Cord Stimulator

Background: Neuromodulation has been used in the management of chronic pain for well over 30 years and is becoming increasingly relevant in the face of the ongoing opioid epidemic. Although this therapy continues to provide pain relief and improvement in function to patients with a wide variety of pathologies, several complications have been described ranging from lead migration to development of a granuloma causing cord compression. Although not described in the literature, a pulmonary embolism can be one of the rare complications of a spinal cord stimulation procedure, and when it happens during the trial period of spinal cord stimulation, it involves significant challenges in the clinical management of anticoagulation in the patient. Case Report: We present a case in which a patient developed bilateral pulmonary emboli (PE) during the trial phase of spinal cord stimulation. The patient did have a prior history of PE, had an inferior vena cava filter in place, and was on anticoagulation, which was held as per the current American Society of Regional Anesthesia guidelines prior to the spinal cord stimulator (SCS) trial. Conclusion: A pulmonary embolus is a possible complication from an SCS trial, especially in patients with preexisting thromboembolic risk factors. Management must involve multidisciplinary care focused on balancing the risks of thrombosis with those from a potential epidural hematoma at the time of lead removal. Key words: Spinal cord stimulation, pulmonary embolus, spinal cord stimulator complications, neuromodulation, venous thromboembolism, SCS trial, VTE, PE

scholarly journals Bilateral pulmonary emboli in an amateur kick boxer: A case report and literature review

2021 ◽  
Vol 9 (9) ◽  
Author(s):  
Elabbass A. Abdelmahmuod ◽  
Aseel Alzibdeh ◽  
Ali Rahil
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Pulmonary Emboli

PP-282 MASSIVE RIGHT MAIN PULMONARY EMBOLI CAUSED BY TRICUSPIT VALVE INFECTIVE ENDOCARDIT: A CASE REPORT

2012 ◽  
Vol 155 ◽  
pp. S193
Author(s):  
M.S. Aydin ◽  
A. Hazar ◽  
A.H. Demirkol ◽  
M. Goz ◽  
Z. Kaya
Keyword(s):  
Case Report ◽  
Pulmonary Emboli

scholarly journals COVID-19 resulting in bilateral pulmonary emboli and a right ventricular thrombus: association or causation? A case report

2020 ◽  
Vol 4 (5) ◽  
pp. 1-5
Author(s):  
Jason G Kaplan ◽  
Arjun Kanwal ◽  
Ryan Malek ◽  
John Q Dickey ◽  
Richard Keirn ◽  
...  
Keyword(s):  
Case Report ◽  
Right Ventricular ◽  
Hypercoagulable State ◽  
Pulmonary Emboli ◽  
Rehabilitation Unit ◽  
Respiratory Status ◽  
Ventricular Thrombus ◽  
Case Summary ◽  
Global Pandemic ◽  
Viral Illness

Abstract Background SARS-CoV-2 is a novel viral illness originating out of Wuhan China in late 2019. This global pandemic has infected nearly 3 million people and accounted for 200 000 deaths worldwide, with those numbers still climbing. Case summary We present a 54-year-old patient who developed respiratory failure requiring endotracheal intubation from her infection with SARS-CoV-2. This patient was subsequently found to have a right ventricular thrombus and bilateral pulmonary emboli, likely contributing to her respiratory status. On the 14th day of hospitalization, the patient was successfully extubated, and 5 days later was discharged to the rehabilitation unit. Discussion SARS-CoV-2 presents primarily with pulmonary symptoms; however, many patients, particularly those who are severely ill, exhibit adverse events related to hypercoagulability. The exact mechanism explaining this hypercoagulable state has yet to be elucidated, but these thrombotic events have been linked to the increased inflammation caused by SARS-CoV-2. This novel viral illness is still largely misunderstood, but the hypercoagulable state, seen in severely ill patients, appears to play a major role in disease progression and prognosis.

Septic pulmonary emboli caused by Tsukamurella inchonensis: A case report

2020 ◽  
Author(s):  
Kazuyoshi Gotoh ◽  
I Putu Bayu Mayura ◽  
Hideharu Hagiya ◽  
Kyoichi Obata ◽  
Tatsuo Ogawa ◽  
...  
Keyword(s):  
Case Report ◽  
Pulmonary Emboli
Sign in / Sign up

Export Citation Format

Share Document